Parnell Pharmaceuticals Holdings Ltd [●] Ordinary Shares UNDERWRITING AGREEMENTUnderwriting Agreement • June 10th, 2014 • Parnell Pharmaceuticals Holdings Pty LTD • Pharmaceutical preparations • New York
CREDIT AGREEMENT dated as of January 23, 2014 among PARNELL PHARMACEUTICALS HOLDINGS PTY LTD, and PARNELL, INC. as Borrowers, THE SUBSIDIARIES OF THE BORROWERS, as Guarantors, THE LENDERS PARTY HERETO, as Lenders, and SWK FUNDING LLC, as Agent, Sole...Credit Agreement • June 10th, 2014 • Parnell Pharmaceuticals Holdings Pty LTD • Pharmaceutical preparations
This Credit Agreement (“Agreement”) dated as of January 23, 2014, among PARNELL PHARMACEUTICALS HOLDINGS PTY LTD, a proprietary company limited by shares incorporated under the laws of Australia (“Australian Borrower”), PARNELL, INC., a corporation incorporated under the laws of the state of Delaware, United States of America (“U.S. Borrower”, and together with Australian Borrower, each individually, a “Borrower”, and collectively, the “Borrowers”), the Guarantors (as defined herein), the financial institutions party hereto from time to time as Lenders (“Lenders”) and SWK Funding LLC (in its individual capacity, “SWK”), as Agent for all Lenders.
SUPPLY AGREEMENT ON GONADORELIN ACETATESupply Agreement • June 10th, 2014 • Parnell Pharmaceuticals Holdings Pty LTD • Pharmaceutical preparations
ContractSupply Agreement • June 10th, 2014 • Parnell Pharmaceuticals Holdings Pty LTD • Pharmaceutical preparations • New York
CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH AN ASTERISK ***, HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
Supply Agreement for Pentosan Polysufate Active Pharmaceutical Ingredient Between Parnell Manufacturing Pty Ltd (ABN 46 138 251 582) and IDT Australia Limited (ABN 66 066 522 970) Effective Date: 3 December 2013Supply Agreement • June 10th, 2014 • Parnell Pharmaceuticals Holdings Pty LTD • Pharmaceutical preparations • Victoria
CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH AN ASTERISK ***, HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
